Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1799 2
1800 34
1801 2
1802 4
1804 1
1805 1
1806 118
1807 1
1808 12
1810 2
1811 2
1814 3
1817 9
1818 2
1819 60
1821 1
1823 14
1824 1
1826 2
1827 18
1828 19
1829 14
1831 190
1832 1
1833 24
1838 9
1839 34
1840 6
1841 22
1842 12
1843 62
1844 26
1845 6
1846 34
1847 13
1848 11
1849 7
1850 10
1851 226
1852 11
1853 10
1854 5
1855 55
1856 12
1857 7
1858 158
1859 117
1860 96
1861 164
1862 4
1863 1
1864 4
1865 4
1866 1
1867 11
1868 140
1869 93
1870 81
1871 8
1872 12
1873 11
1874 235
1875 52
1876 63
1877 199
1878 57
1879 44
1880 242
1881 173
1882 45
1883 18
1884 13
1885 218
1886 11
1887 41
1888 13
1889 55
1890 296
1891 12
1892 49
1893 278
1894 578
1895 168
1896 63
1897 60
1898 131
1899 164
1900 139
1901 14
1902 288
1903 18
1904 13
1905 58
1906 46
1907 14
1908 20
1909 17
1910 24
1911 21
1912 64
1913 28
1914 28
1915 39
1916 50
1917 343
1918 32
1919 28
1920 29
1921 123
1922 621
1923 127
1924 55
1925 742
1926 51
1927 35
1928 60
1929 220
1930 48
1931 122
1932 66
1933 23
1934 46
1935 44
1936 100
1937 28
1938 48
1939 186
1940 115
1941 22
1942 47
1943 78
1944 36
1945 343
1946 1119
1947 934
1948 1144
1949 1255
1950 1570
1951 1830
1952 1959
1953 2091
1954 2224
1955 2188
1956 1985
1957 2418
1958 2073
1959 2448
1960 4730
1961 2892
1962 2661
1963 3589
1964 3735
1965 4411
1966 5821
1967 5595
1968 5187
1969 5919
1970 6379
1971 4823
1972 5113
1973 5303
1974 6749
1975 12816
1976 14236
1977 12966
1978 13118
1979 13908
1980 15051
1981 17215
1982 17040
1983 20923
1984 22052
1985 24792
1986 26203
1987 27897
1988 29547
1989 34469
1990 36374
1991 35405
1992 38652
1993 37946
1994 41681
1995 43622
1996 44744
1997 44998
1998 45973
1999 48178
2000 53237
2001 56991
2002 55594
2003 59273
2004 65696
2005 72606
2006 75774
2007 80422
2008 85590
2009 94429
2010 94393
2011 101625
2012 107477
2013 117963
2014 128904
2015 137359
2016 129394
2017 134540
2018 147242
2019 156985
2020 190401
2021 198809
2022 208939
2023 223074
2024 96715
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

3,381,747 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 5-farnesanolide
Page 1
Interleukin 15: A key cytokine for immunotherapy.
Patidar M, Yadav N, Dalai SK. Patidar M, et al. Cytokine Growth Factor Rev. 2016 Oct;31:49-59. doi: 10.1016/j.cytogfr.2016.06.001. Epub 2016 Jun 7. Cytokine Growth Factor Rev. 2016. PMID: 27325459 Review.
In addition, IL-15 can be targeted by antibody- or mutant IL-15 therapy to reduce inflammation. ...In this article, we review the functions, expression, and regulation of IL-15 for designing an improved IL-15-based therapy targeting the IL-15 si …
In addition, IL-15 can be targeted by antibody- or mutant IL-15 therapy to reduce inflammation. ...In this article, we review …
IL-15 in the Combination Immunotherapy of Cancer.
Waldmann TA, Dubois S, Miljkovic MD, Conlon KC. Waldmann TA, et al. Front Immunol. 2020 May 19;11:868. doi: 10.3389/fimmu.2020.00868. eCollection 2020. Front Immunol. 2020. PMID: 32508818 Free PMC article. Review.
To circumvent checkpoints, trials of IL-15 in combination with other anticancer agents were initiated. Tumor-bearing mice receiving IL-15 with antibodies to CTLA-4 and PD-L1 manifested marked prolongation of survival compared to mice receiving IL-15 with eith …
To circumvent checkpoints, trials of IL-15 in combination with other anticancer agents were initiated. Tumor-bearing mice receiving I …
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Wischhusen J, Melero I, Fridman WH. Wischhusen J, et al. Front Immunol. 2020 May 19;11:951. doi: 10.3389/fimmu.2020.00951. eCollection 2020. Front Immunol. 2020. PMID: 32508832 Free PMC article. Review.
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a divergent member of the transforming growth factor beta superfamily. ...GDF-15 has thus been widely explored as a biomarker for disease prognosis. ...
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a divergent member of the transform …
Oxygen-15.
[No authors listed] [No authors listed] 2023 Oct 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Oct 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999854 Free Books & Documents. Review.
Information in this record refers to the use of oxygen-15 radiopharmaceuticals as diagnostic agents. United States and international authorities state that breastfeeding need not be interrupted after administration of radiopharmaceuticals containing oxygen-15.[1,2]. …
Information in this record refers to the use of oxygen-15 radiopharmaceuticals as diagnostic agents. United States and international …
Interleukin-15 in autoimmunity.
Allard-Chamard H, Mishra HK, Nandi M, Mayhue M, Menendez A, Ilangumaran S, Ramanathan S. Allard-Chamard H, et al. Cytokine. 2020 Dec;136:155258. doi: 10.1016/j.cyto.2020.155258. Epub 2020 Sep 9. Cytokine. 2020. PMID: 32919253 Review.
Interleukin-15 (IL-15) is a member of the IL-2 family of cytokines, which use receptor complexes containing the common gamma (gamma(c)) chain for signaling. ...We discuss the complexities of IL-15 signaling in autoimmunity and explore potential immunotherapeu …
Interleukin-15 (IL-15) is a member of the IL-2 family of cytokines, which use receptor complexes containing the common gamma ( …
Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
Mortier E, Quéméner A, Vusio P, Lorenzen I, Boublik Y, Grötzinger J, Plet A, Jacques Y. Mortier E, et al. J Biol Chem. 2006 Jan 20;281(3):1612-9. doi: 10.1074/jbc.M508624200. Epub 2005 Nov 11. J Biol Chem. 2006. PMID: 16284400 Free article.
Interleukin-15 (IL-15) is crucial for the generation of multiple lymphocyte subsets (natural killer (NK), NK-T cells, and memory CD8 T cells), and transpresentation of IL-15 by monocytes and dendritic cells has been suggested to be the dominant activating pro …
Interleukin-15 (IL-15) is crucial for the generation of multiple lymphocyte subsets (natural killer (NK), NK-T cells, and memo …
Interleukin-15 in Outcomes of Pregnancy.
Gordon SM. Gordon SM. Int J Mol Sci. 2021 Oct 14;22(20):11094. doi: 10.3390/ijms222011094. Int J Mol Sci. 2021. PMID: 34681751 Free PMC article. Review.
Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. ...Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in …
Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function o …
Heterodimeric IL-15 in Cancer Immunotherapy.
Bergamaschi C, Stravokefalou V, Stellas D, Karaliota S, Felber BK, Pavlakis GN. Bergamaschi C, et al. Cancers (Basel). 2021 Feb 17;13(4):837. doi: 10.3390/cancers13040837. Cancers (Basel). 2021. PMID: 33671252 Free PMC article. Review.
Immunotherapy has emerged as a valuable strategy for the treatment of many cancer types. Interleukin-15 (IL-15) promotes the growth and function of cytotoxic CD8(+) T and natural killer (NK) cells. It also enhances leukocyte trafficking and stimulates tumor-infiltra …
Immunotherapy has emerged as a valuable strategy for the treatment of many cancer types. Interleukin-15 (IL-15) promotes the g …
Synthesis of (15) N-labelled 3,5-dimethylpyridine.
Schubert M, Limbach HH, Elguero J. Schubert M, et al. J Labelled Comp Radiopharm. 2019 Dec;62(14):914-919. doi: 10.1002/jlcr.3807. Epub 2019 Nov 14. J Labelled Comp Radiopharm. 2019. PMID: 31677176 Free PMC article.
(15) N-labelled pyridines are liquid- and solid-state nuclear magnetic resonance (NMR) probes for chemical and biological environments because their (15) N chemical shifts are sensitive to hydrogen-bond and protonation states. ...As an example, we have synthesized 3 …
(15) N-labelled pyridines are liquid- and solid-state nuclear magnetic resonance (NMR) probes for chemical and biological environment …
5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1.
Green AR, Freedman C, Tena J, Tourdot BE, Liu B, Holinstat M, Holman TR. Green AR, et al. Biochemistry. 2018 Dec 4;57(48):6726-6734. doi: 10.1021/acs.biochem.8b00889. Epub 2018 Nov 15. Biochemistry. 2018. PMID: 30407793 Free PMC article.
The reaction of 5 S,15 S-dihydroperoxyeicosatetraenoic acid (5,15-diHpETE) with human 5-lipoxygenase (LOX), human platelet 12-LOX, and human reticulocyte 15-LOX-1 was investigated to determine the reactivity and relative rates of producing lipoxins (LXs). 5-L …
The reaction of 5 S,15 S-dihydroperoxyeicosatetraenoic acid (5,15-diHpETE) with human 5-lipoxygenase (LOX), human platelet 12- …
3,381,747 results
You have reached the last available page of results. Please see the User Guide for more information.